Innomedica is currently running
Ulcerative colitis drug trial
Innomedica Medical Center invites patients with moderate to severe active ulcerative colitis to participate in a clinical drug trial. The purpose of the study is to determine the safety and efficacy of a new experimental drug (MORF-057).